Focal therapy in prostate cancer-report from a consensus panel.
PURPOSE: To establish a consensus in relation to case selection, conduct of therapy, and outcomes that are associated with focal therapy for men with localized prostate cancer. MATERIAL AND METHODS: Urologic surgeons, radiation oncologists, radiologists, and histopathologists from North America and Europe participated in a consensus workshop on focal therapy for prostate cancer. The consensus process was face to face within a structured meeting, in which pertinent clinical issues were raised, discussed, and agreement sought. Where no agreement was possible, this was acknowledged, and the nature of the disagreement noted. RESULTS: Candidates for focal treatment should have unilateral low- to intermediate-risk disease with clinical stage
de la Rosette, J; Ahmed, H; Barentsz, J; Johansen, TB; Brausi, M; Emberton, M; Frauscher, F; Greene, D; Harisinghani, M; Haustermans, K; Heidenreich, A; Kovacs, G; Mason, M; Montironi, R; Mouraviev, V; de Reijke, T; Taneja, S; Thuroff, S; Tombal, B; Trachtenberg, J; Wijkstra, H; Polascik, T
Volume / Issue
Start / End Page
Pubmed Central ID
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)